Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)
China · Delayed Price · Currency is CNY 24.08
+0.02 (0.08%)
Oct 28, 2026, 11:30 AM CST
SHA:600993 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,929 | 3,867 | 3,728 | 3,137 | 3,532 | 3,385 |
Revenue Growth | 4.80% | 3.72% | 18.85% | -11.20% | 4.35% | 21.26% |
Gross Profit Gross Profit Growth | 1,877 | 1,901 | 1,731 | 1,307 | 1,494 | 1,366 |
Operating Income Operating Income Growth | 658.03 | 644.71 | 587.12 | 384.73 | 494.16 | 453.38 |
Net Income Net Income Growth | 600.88 | 581.49 | 528.09 | 443.25 | 478.57 | 464.59 |
Earnings Per Share EPS Growth | 1.39 | 1.35 | 1.23 | 1.03 | 1.11 | 1.08 |
EPS Growth | 6.22% | 9.76% | 19.42% | -7.21% | 2.78% | 11.34% |
Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Pharmaceutical Business Segment Pharmaceutical Business Segment Growth | 1,167 |
Pharmaceutical Industry Division Pharmaceutical Industry Division Growth | 2,402 |
Undistributed Amount Undistributed Amount Growth | 22.48 |
Medical Services Division Medical Services Division Growth | 421.83 |
Offsets between Segments Offsets between Segments Growth | -146.37 |
Total Total Growth | 3,867 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,507 | 2,594 | 3,157 | 3,051 | 3,307 | 2,679 |
Total Debt Total Debt Growth | 93.48 | 99.13 | 234.22 | 272.29 | 638.23 | 182.35 |
Net Cash (Debt) Net Cash Growth | 2,414 | 2,495 | 2,923 | 2,779 | 2,669 | 2,496 |
Net Cash Growth | -12.69% | -14.64% | 5.19% | 4.14% | 6.90% | 13.90% |
Net Cash Per Share Net Cash Per Share Growth | 5.59 | 5.79 | 6.81 | 6.46 | 6.19 | 5.80 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 720.12 | 600.44 | 497.61 | 604.07 | 341.85 | 597.17 |
Capital Expenditures CapEx Growth | -81.88 | -119.37 | -203.85 | -248.36 | -75.01 | -65.1 |
Free Cash Flow Free Cash Flow Growth | 638.24 | 481.07 | 293.76 | 355.7 | 266.84 | 532.07 |
Free Cash Flow Growth | 54.49% | 63.76% | -17.41% | 33.30% | -49.85% | 123.96% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 47.76% | 49.16% | 46.43% | 41.68% | 42.30% | 40.36% |
Operating Margin | 16.75% | 16.67% | 15.75% | 12.26% | 13.99% | 13.39% |
Pretax Margin | 18.62% | 18.34% | 17.64% | 16.73% | 15.83% | 16.19% |
Profit Margin | 15.29% | 15.04% | 14.17% | 14.13% | 13.55% | 13.73% |
FCF Margin | 16.24% | 12.44% | 7.88% | 11.34% | 7.55% | 15.72% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.700 | 0.700 | 0.620 | 0.400 | 0.350 | 0.350 |
Dividend Per Share Growth | 12.90% | 12.90% | 55.00% | 14.29% | 0% | 16.67% |
Dividend Yield | 2.91% | 2.50% | 2.38% | 1.65% | 1.55% | 1.22% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 17.31 | 20.76 | 21.31 | 23.52 | 20.36 | 26.68 |
Forward PE | 15.57 | 16.87 | 18.47 | 21.80 | 21.80 | 21.80 |
P/FCF Ratio | 16.25 | 25.09 | 38.31 | 29.30 | 36.51 | 23.30 |
PS Ratio | 2.64 | 3.12 | 3.02 | 3.32 | 2.76 | 3.66 |